At a glance
ClinicalIndex Comparison RecordN/ACompleted· 162 enrolled
Drug / intervention
Nucleus CI532 cochlear implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Post-market Hearing Performance Outcome in a Cohort of CI532 Recipients
In Brief
An observational study evaluating Nucleus CI532 cochlear implant for Hearing Loss. Completed, enrolled 162 participants across 5 sites.
Detailed Summary
The aim of this retrospective study is to collect and assess hearing performance data that have been measured by five clinics in Germany as part of their clinical routine in recipients implanted with a commercial CI532.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartMar 2017
Primary CompletionAug 2018
TodayJul 2026
First PostedFeb 1, 2017
Enrollment StartMar 14, 2017
Primary CompletionAug 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.4 years ago
Interventions
Nucleus CI532 cochlear implantdevice
Retrospective study of the commercial CI532 cochlear implant